Denise J. JamiesonNatapakwa SkunodomThanyanan ChaowanachanAnuvat RoongpisuthipongWilliam A. BowerTawee ChotpitayasunondhWendy Bhanich SupapolWendi L. KuhnertWimol SiriwasinJeffrey WienerSanay ChearskulMichelle S. McConnellNathan ShafferNational Center for Chronic Disease Prevention and Health PromotionThailand Ministry of Public HealthMahidol UniversityCenters for Disease Control and PreventionUniversity of Toronto Faculty of MedicineRajavithi Hospital2018-07-122018-07-122008-12-01Infectious Diseases in Obstetrics and Gynecology. Vol.2008, (2008)10980997106474492-s2.0-59549101379https://repository.li.mahidol.ac.th/handle/20.500.14594/19460Objective. The purpose of this study was to describe the epidemiology of coinfection with hepatitis C virus (HCV) and HIV among a cohort of pregnant Thai women. Methods. Samples from 1771 pregnant women enrolled in three vertical transmission of HIV studies in Bangkok, Thailand, were tested for HCV. Results. Among HIV-infected pregnant women, HCV seroprevelance was 3.8% and the active HCV infection rate was 3.0%. Among HIV-uninfected pregnant women, 0.3% were HCV-infected. Intravenous drug use by the woman was the factor most strongly associated with HCV seropositivity. Among 48 infants tested for HCV who were born to HIV/HCV coinfected women, two infants were HCV infected for an HCV transmission rate of 4.2% (95% 0.51-14.25%). Conclusions. HCV seroprevalence and perinatal transmission rates were low among this Thai cohort of HIV-infected pregnant women. Copyright © 2008 Denise J. Jamieson et al.Mahidol UniversityMedicineArticleSCOPUS10.1155/2008/840948